Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder

Makito Miyake, Shunta Hori, Yosuke Morizawa, +18

Oncotarget

Collagen Type XiiiTumor InvasionUrologyGenitourinary CancerMedicine +13

Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort

Makito Miyake, Yoshihiro Tatsumi, Daisuke Gotoh, +16

International Journal of Molecular Sciences

Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy

Makito Miyake, Yosuke Morizawa, Shunta Hori, +14

Oncology

Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens

Makito Miyake, Kenta Ohnishi, Shunta Hori, +16

Cells

Probiotics enhances anti‐tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer

Makito Miyake, Yuki Oda, Takuya Owari, +14

Cancer Science

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy

Yoshitaka Itami, Makito Miyake, Yoshihiro Tatsumi, +12

International Journal of Clinical Oncology

Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicine +5

Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort

Makito Miyake, Nobutaka Nishimura, Yuki Oda, +22

Japanese Journal of Clinical Oncology

Dual benefit of supplementary oral 5‐aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model

Makito Miyake, Nobumichi Tanaka, Shunta Hori, +15

The Prostate

Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study

Makito Miyake, Takuto Shimizu, Yuki Oda, +16

Japanese Journal of Clinical Oncology

Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder

Yoshitaka Itami, Makito Miyake, Sayuri Ohnishi, +16

Diagnostics